| Literature DB >> 24900621 |
Rajeev Goswami1, Subhendu Mukherjee1, Gerd Wohlfahrt2, Chakshusmathi Ghadiyaram1, Jwala Nagaraj1, Beeram Ravi Chandra1, Ramesh K Sistla1, Leena K Satyam1, Dodheri S Samiulla1, Anu Moilanen3, Hosahalli S Subramanya1, Murali Ramachandra1.
Abstract
Matriptase belongs to trypsin-like serine proteases involved in matrix remodeling/degradation, growth regulation, survival, motility, and cell morphogenesis. Herein, we report a structure-based approach, which led to the discovery of sulfonamide and amide derivatives of pyridyl bis(oxy)benzamidine as potent and selective matriptase inhibitors. Co-crystal structures of selected compounds in complex with matriptase supported compound designing. Additionally, WaterMap analyses indicated the possibility of occupying a distinct pocket within the catalytic domain, exploration of which resulted in >100-fold improvement in potency. Co-crystal structure of 10 with matriptase revealed critical interactions leading to potent target inhibition and selectivity against other serine proteases.Entities:
Keywords: Matriptase; SAR; cancer; crystal structure; pyridyl dibenzimidamide
Year: 2013 PMID: 24900621 PMCID: PMC4027570 DOI: 10.1021/ml400213v
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345